Skip to main content

Fortress Biotech, Inc. (FBIO) Stock Forecast

Data as of Aug 9, 2026

Healthcare · Current price $2.67 (-3.61%)

Consensus Target
$5.00
Upside
+87.3%
Analysts
1
Rating
Buy(2.00)

Price Target Range

Low $5.00High $5.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

No analyst price targets available.

FBIO vs Sector & Market

MetricFBIOHealthcare AvgLarge Cap Avg
Analyst Rating2.002.252.42
Analyst Count1818
Target Upside+87.3%+16286.3%+14.7%
P/E Ratio0.843.5936.06

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$22M$22M$22M1
2026-12-31$24M$24M$24M1
2027-12-31$145M$145M$146M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$-0.16$-0.16$-0.161
2026-12-31$-0.14$-0.14$-0.141
2027-12-31$1.51$1.51$1.511

Frequently Asked Questions

What is the analyst consensus for FBIO?

The consensus among 1 analysts covering Fortress Biotech, Inc. (FBIO) is Buy with an average price target of $5.00.

What is the highest price target for FBIO?

The highest analyst price target for FBIO is $5.00.

What is the lowest price target for FBIO?

The lowest analyst price target for FBIO is $5.00.

How many analysts cover FBIO?

1 analysts have issued ratings for Fortress Biotech, Inc. in the past 12 months.

Is FBIO a buy or sell right now?

Based on 1 analyst ratings, FBIO has a consensus rating of Buy (2.00/5) with a +87.3% upside to the consensus target of $5.00.

What are the earnings estimates for FBIO?

Analysts estimate FBIO will report EPS of $-0.16 for the period ending 2026-09-30, with revenue estimated at $22M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.